August 20, 2024

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

August 17, 2024

Nivolumab’s role in esophageal cancer neoadjuvant therapy: Dr. Jennifer Eads (study EA2174)

August 14, 2024

The August 2024 News from ECOG-ACRIN blog is now available

August 1, 2024

Advocate Health Care and Aurora Health Care cancer clinics join the EAQ211 trial, which seeks to determine why young lymphoma survivors are at high risk for other health problems

July 9, 2024

ECOG-ACRIN research advocate and prostate cancer survivor Brian Jones is profiled in Cancer Today

July 3, 2024

The July 2024 News from ECOG-ACRIN blog is now available

July 2, 2024

The Summer 2024 advocacy blog, Considering Clinical Trials, is now available

July 1, 2024

New Patient Video: Study chair Dr. Raquibul Hannan and advocate Glenn Sykes discuss the SOAR trial for patients with kidney cancer

June 14, 2024

E1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)

ECOG-ACRIN Cancer Research Group